Hypertension and its Management in the Elderly

Seminars in Nephrology

Volumn 29, Issue 6, 2009, Pages 604-609

  Burney, Basil O ^a   Bakris, George L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Elderly; hypertension; kidney; nephropathy

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; LISINOPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; PLACEBO; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL PLUS VERAPAMIL;

AGING; ARTHRITIS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG CHOICE; DRUG EFFICACY; EDEMA; ELDERLY CARE; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK REDUCTION; SIDE EFFECT; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; WEIGHT REDUCTION;

AGED; AGING; ANTIHYPERTENSIVE AGENTS; DIET, CARBOHYDRATE-RESTRICTED; DIET, REDUCING; HUMANS; HYPERTENSION; RISK REDUCTION BEHAVIOR;

EID: 71549115751     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2009.07.005     Document Type: Article

References (22)

1. Lewington S., Clarke R., Qizilbash N., Peto R., and Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
2. Weber M.A. Exploring a new definition of hypertension. Rev Cardiovasc Med 6 (2005) 164-172
3. Ostchega Y., Dillon C.F., Hughes J.P., Carroll M., and Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 55 (2007) 1056-1065
4. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
5. Benetos A., Thomas F., Bean K., Gautier S., Smulyan H., and Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 162 (2002) 577-581
6. Franklin S.S., Gustin W., Wong N.D., et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96 (1997) 308-315
7. Phillips P.A., Hodsman G.P., and Johnston C.I. Neuroendocrine mechanisms and cardiovascular homeostasis in the elderly. Cardiovasc Drugs Ther 4 Suppl 6 (1991) 1209-1213
8. Campese V.M. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 23 (1994) 531-550
9. Zemel M.B., and Sowers J.R. Salt sensitivity and systemic hypertension in the elderly. Am J Cardiol 61 (1988) 7H-12H
10. Messerli F.H., Kupfer S., and Pepine C.J. J curve in hypertension and coronary artery disease. Am J Cardiol 95 (2005) 160
11. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (1991) 3255-3264
12. Messerli F.H., Mancia G., Conti C.R., et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?. Ann Intern Med 144 (2006) 884-893
13. Stevens J.C. Detection of tastes in mixture with other tastes: issues of masking and aging. Chem Senses 21 (1996) 211-221
14. Whelton P.K., Appel L.J., Espeland M.A., et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 279 (1998) 839-846
15. de Leeuw P.W. Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective. Drugs 51 (1996) 179-187
16. Johnson A.G. NSAIDs and increased blood pressure. What is the clinical significance?. Drug Saf 17 (1997) 277-289
17. Whelton A., Schulman G., Wallemark C., et al. Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 160 (2000) 1465-1470
18. Turnbull F., Neal B., Ninomiya T., et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 336 (2008) 1121-1123
19. Perry Jr. H.M., Davis B.R., Price T.R., et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 284 (2000) 465-471
20. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008) 1887-1898
21. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
22. Wing L.M., Reid C.M., Ryan P., et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348 (2003) 583-592